CINXE.COM

<!DOCTYPE html> <html lang="en-US" class="no-js"> <head>  <script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" type="text/javascript" charset="UTF-8" data-domain-script="0192e7ff-6cd0-7eeb-a526-454b4ec9d90f" ></script> <script type="text/javascript"> function OptanonWrapper() { } </script>  <meta charset="UTF-8"> <meta http-equiv="X-UA-Compatible" content="IE=edge"> <meta name="viewport" content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0"> <link rel="profile" href="http://gmpg.org/xfn/11">  <link rel="shortcut icon" href="https://tinygems.com/wp-content/themes/tinygems/favicon.ico" /> <meta property="og:image" content="https://tinygems.com/wp-content/themes/tinygems/fb-og-cnw.png" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/css/angular-styles.css?1732381775" /> <link rel="stylesheet" href="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.css" /> <link rel="apple-touch-icon-precomposed" href="https://tinygems.com/wp-content/themes/tinygems/ios-icon.png"/> <script src="https://ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular.min.js"></script> <script src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-animate.js"></script>  <link rel="stylesheet" href="https://use.typekit.net/xip4tqq.css"> <script>(function(html){html.className = html.className.replace(/\bno-js\b/,'js')})(document.documentElement);</script> <meta name='robots' content='index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1' />  <title>Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program - TinyGems</title> <link rel="canonical" href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/" /> <meta property="og:locale" content="en_US" /> <meta property="og:type" content="article" /> <meta property="og:title" content="Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program - TinyGems" /> <meta property="og:description" content="Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, … Continue reading "Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program"" /> <meta property="og:url" content="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/" /> <meta property="og:site_name" content="TinyGems" /> <meta property="article:publisher" content="https://www.facebook.com/tinygems.com" /> <meta property="article:published_time" content="2024-08-12T16:00:00+00:00" /> <meta property="article:modified_time" content="2024-08-12T16:42:58+00:00" /> <meta name="author" content="Christian Amiscua" /> <meta name="twitter:card" content="summary_large_image" /> <meta name="twitter:creator" content="@tinygems" /> <meta name="twitter:site" content="@tinygems" /> <meta name="twitter:label1" content="Written by" /> <meta name="twitter:data1" content="Christian Amiscua" /> <meta name="twitter:label2" content="Est. reading time" /> <meta name="twitter:data2" content="4 minutes" /> <script type="application/ld+json" class="yoast-schema-graph">{"@context":"https://schema.org","@graph":[{"@type":"Article","@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/#article","isPartOf":{"@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/"},"author":{"name":"Christian Amiscua","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa"},"headline":"Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program","datePublished":"2024-08-12T16:00:00+00:00","dateModified":"2024-08-12T16:42:58+00:00","mainEntityOfPage":{"@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/"},"wordCount":796,"publisher":{"@id":"https://tinygems.com/#organization"},"articleSection":["Tiny Gem"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/","url":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/","name":"Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program - TinyGems","isPartOf":{"@id":"https://tinygems.com/#website"},"datePublished":"2024-08-12T16:00:00+00:00","dateModified":"2024-08-12T16:42:58+00:00","breadcrumb":{"@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/"]}]},{"@type":"BreadcrumbList","@id":"https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https://tinygems.com/"},{"@type":"ListItem","position":2,"name":"NewsRoom Articles","item":"https://tinygems.com/newsroom/newsroom-articles/"},{"@type":"ListItem","position":3,"name":"Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program"}]},{"@type":"WebSite","@id":"https://tinygems.com/#website","url":"https://tinygems.com/","name":"TinyGems","description":"Spotlighting undiscovered companies with enormous upside potential.","publisher":{"@id":"https://tinygems.com/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https://tinygems.com/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https://tinygems.com/#organization","name":"TinyGems","url":"https://tinygems.com/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/logo/image/","url":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","contentUrl":"https://tinygems.com/wp-content/uploads/tg-amp-logo.png","width":190,"height":142,"caption":"TinyGems"},"image":{"@id":"https://tinygems.com/#/schema/logo/image/"},"sameAs":["https://www.facebook.com/tinygems.com","https://twitter.com/tinygems"]},{"@type":"Person","@id":"https://tinygems.com/#/schema/person/d63601243e945851080e09e3984c0baa","name":"Christian Amiscua","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https://tinygems.com/#/schema/person/image/","url":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","contentUrl":"https://secure.gravatar.com/avatar/8a84f51d57cade327d2817ae67a6d290?s=96&d=mm&r=g","caption":"Christian Amiscua"},"url":"https://tinygems.com/author/tg_ibn_christian/"}]}</script>  <link rel="amphtml" href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/amp/" /><meta name="generator" content="AMP for WP 1.0.98"/><link rel='dns-prefetch' href='//ajax.googleapis.com' /> <link rel='dns-prefetch' href='//cdnjs.cloudflare.com' /> <link rel='stylesheet' id='wp-block-library-css' href='https://tinygems.com/wp-includes/css/dist/block-library/style.min.css' type='text/css' media='all' /> <style id='classic-theme-styles-inline-css' type='text/css'> /*! This file is auto-generated */ .wp-block-button__link{color:#fff;background-color:#32373c;border-radius:9999px;box-shadow:none;text-decoration:none;padding:calc(.667em + 2px) calc(1.333em + 2px);font-size:1.125em}.wp-block-file__button{background:#32373c;color:#fff;text-decoration:none} </style> <style id='global-styles-inline-css' type='text/css'> body{--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;--wp--preset--spacing--20: 0.44rem;--wp--preset--spacing--30: 0.67rem;--wp--preset--spacing--40: 1rem;--wp--preset--spacing--50: 1.5rem;--wp--preset--spacing--60: 2.25rem;--wp--preset--spacing--70: 3.38rem;--wp--preset--spacing--80: 5.06rem;--wp--preset--shadow--natural: 6px 6px 9px rgba(0, 0, 0, 0.2);--wp--preset--shadow--deep: 12px 12px 50px rgba(0, 0, 0, 0.4);--wp--preset--shadow--sharp: 6px 6px 0px rgba(0, 0, 0, 0.2);--wp--preset--shadow--outlined: 6px 6px 0px -3px rgba(255, 255, 255, 1), 6px 6px rgba(0, 0, 0, 1);--wp--preset--shadow--crisp: 6px 6px 0px rgba(0, 0, 0, 1);}:where(.is-layout-flex){gap: 0.5em;}:where(.is-layout-grid){gap: 0.5em;}body .is-layout-flow > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-flow > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-flow > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignleft{float: left;margin-inline-start: 0;margin-inline-end: 2em;}body .is-layout-constrained > .alignright{float: right;margin-inline-start: 2em;margin-inline-end: 0;}body .is-layout-constrained > .aligncenter{margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > :where(:not(.alignleft):not(.alignright):not(.alignfull)){max-width: var(--wp--style--global--content-size);margin-left: auto !important;margin-right: auto !important;}body .is-layout-constrained > .alignwide{max-width: var(--wp--style--global--wide-size);}body .is-layout-flex{display: flex;}body .is-layout-flex{flex-wrap: wrap;align-items: center;}body .is-layout-flex > *{margin: 0;}body .is-layout-grid{display: grid;}body .is-layout-grid > *{margin: 0;}:where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;}:where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;} .wp-block-navigation a:where(:not(.wp-element-button)){color: inherit;} :where(.wp-block-post-template.is-layout-flex){gap: 1.25em;}:where(.wp-block-post-template.is-layout-grid){gap: 1.25em;} :where(.wp-block-columns.is-layout-flex){gap: 2em;}:where(.wp-block-columns.is-layout-grid){gap: 2em;} .wp-block-pullquote{font-size: 1.5em;line-height: 1.6;} </style> <link rel='stylesheet' id='contact-form-7-css' href='https://tinygems.com/wp-content/plugins/contact-form-7/includes/css/styles.css' type='text/css' media='all' /> <link rel='stylesheet' id='genericons-css' href='https://tinygems.com/wp-content/themes/tinygems/genericons/genericons.css' type='text/css' media='all' /> <link rel='stylesheet' id='font-awesome-css' href='https://tinygems.com/wp-content/themes/tinygems/css/fontawesome-all.min.css' type='text/css' media='all' /> <link rel='stylesheet' id='tinygems-style-css' href='https://tinygems.com/wp-content/themes/tinygems/style.css' type='text/css' media='all' /> <link rel='stylesheet' id='customstyles-css' href='https://tinygems.com/wp-content/themes/tinygems/css/styles.css?1732381775' type='text/css' media='all' /> <link rel='stylesheet' id='tablepress-default-css' href='https://tinygems.com/wp-content/plugins/tablepress/css/build/default.css' type='text/css' media='all' /> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery.min.js" id="jquery-core-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/jquery/jquery-migrate.min.js" id="jquery-migrate-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/fancyBox/source/jquery.fancybox.js" id="fancy-js"></script> <script type="text/javascript" src="//ajax.googleapis.com/ajax/libs/angularjs/1.5.7/angular-resource.js" id="ngresource-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ng-lodash-master/build/ng-lodash.min.js" id="nglodash-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/moment.min.js" id="moment_min-js"></script> <script type="text/javascript" src="https://cdnjs.cloudflare.com/ajax/libs/angular-moment/1.0.0-beta.6/angular-moment.min.js" id="ngmoment-js"></script>  <link rel="https://api.w.org/" href="https://tinygems.com/wp-json/" /><link rel="alternate" type="application/json" href="https://tinygems.com/wp-json/wp/v2/posts/40149" /><link rel='shortlink' href='https://tinygems.com/?p=40149' /> <link rel="alternate" type="application/json+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Flexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program%2F" /> <link rel="alternate" type="text/xml+oembed" href="https://tinygems.com/wp-json/oembed/1.0/embed?url=https%3A%2F%2Ftinygems.com%2Flexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program%2F&format=xml" />  <script async src="https://www.googletagmanager.com/gtag/js?id=G-X56RVJCEJS"></script> <script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-X56RVJCEJS'); </script>  <script async src="https://tag.pearldiver.io/ldc.js?pid=7315ce62cb84c70d74b0564eb49eda9b&aid=16de03f2"></script> </head> <body class="post-template-default single single-post postid-40149 single-format-standard group-blog">   <div class="banner"> <div class="container"> <div class="logo"><a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems.png" alt="tinygems Logo"/></a></div> <div class="banner-right"> <h3>Spotlighting undiscovered companies with enormous upside potential.</h3> <div class="banner-right-flex"> <h4>Contact us: <span>(310) 299-1717</span></h4> <div class="social"> <ul> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div></div> </div>  <div id="hamburger"><span>Spotlighting undiscovered companies with enormous upside potential.</span></div> <div id="Menu"> <div class="menu-main-navigation-container"><ul id="menu-main-navigation" class="menu"><li id="menu-item-31636" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-home menu-item-31636"><a href="https://tinygems.com/">Home</a></li> <li id="menu-item-51" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-51"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-5539" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-5539"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-17" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-17"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34478" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34478"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34872" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34872"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> <li id="menu-item-49" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-49"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> </div> </div>  <div class="article-headlines"> <div class="container"> <div class="headlines-label"><a href="/newsroom/newsroom-articles/">Headlines</a></div> <div id="Headline"> <div class="cycle-slideshow" data-cycle-fx="scrollVert" data-cycle-timeout="5000" data-cycle-slides="> div">  <div> <a href="/gemxx-corp-gemz-announces-definitive-agreement-with-latin-energy-partners-in-strategic-latin-america-venture/">GEMXX Corp. (GEMZ) Announces Definitive Agreement with Latin Energy Partners in Strategic Latin America Venture</a> </div><div> <a href="/mullen-automotive-inc-nasdaq-muln-subsidiary-announces-first-dealership-deal-in-market-projected-to-see-record-sales/">Mullen Automotive Inc. (MULN) Subsidiary Announces First Dealership Deal in Market Projected to See Record Sales</a> </div><div> <a href="/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (LEXX) Hires New CEO in Focus to Pharmaceutical Industry Collaboration and Operations</a> </div><div> <a href="/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </div><div> <a href="/clene-inc-nasdaq-clnn-presents-promising-preliminary-data-on-cnm-au8r-for-rett-syndrome-treatment/">Clene Inc. (CLNN) Presents Promising Preliminary Data on CNM-Au8(R) for Rett Syndrome Treatment</a> </div>   <p></p>   <p></p>  </div> </div> </div> </div> <div class="breadcrumb"><div class="container"><span><span><a href="https://tinygems.com/">Home</a></span> / <span><a href="https://tinygems.com/newsroom/newsroom-articles/">NewsRoom Articles</a></span> / <span class="breadcrumb_last" aria-current="page">Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program</span></span></div></div>  <div class="content"> <div class="container"> <article id="post-40149" class="post-40149 post type-post status-publish format-standard hentry category-tinygem"> <header class="entry-header"> <h1 class="entry-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program</h1> <p class="article-date">August 12, 2024</p> </header> <div class="ad-leader"></div> <div class="single-article-left"> <div class="entry-content"> <ul> <li>The company provided updates for its study programs for 2024, with a focus on its glucagon-like peptide-1 (“GLP-1”) agonist research program, targeting a significant step up in addressing worldwide diabetes and obesity, a tremendous market</li> <li>Lexaria has its Human Pilot Study #3 lined up, as well as its chronic dosing human study, both studies will begin dosing later this year</li> </ul> <p><a href="https://www.investorbrandnetwork.com/clients/lexaria-bioscience-corp/" target="_blank" rel="noreferrer noopener">Lexaria Bioscience (NASDAQ: LEXX)</a>, a global innovator in drug delivery platforms, just released its fiscal report for the third quarter of the 2024 financial year (“Q3, 2024”). Of note was growth in cash and marketable securities from $1.5 million during the same period in the 2023 financial year to $8.5 million as of May 31, 2024. The company reduced certain R&D expenditures and experienced other savings (<a href="https://ibn.fm/HWe5d" target="_blank" rel="noreferrer noopener">https://ibn.fm/HWe5d</a>).</p> <p>Most importantly, however, were the program updates for initiatives it embarked on for 2024. A highlight of its projects has been its glucagon-like peptide-1 (“GLP-1”) agonist research program. GLP-1, a class of drugs, has demonstrated an ability to significantly address diabetes and obesity. What Lexaria’s unique drug delivery platform offers is the added ability to greatly improve the otherwise poor oral bioavailability of GLP-1 drugs, making it possible for simple oral application versus traditional injection, an opportunity of huge implication in the marketplace.</p> <p>Human pilot study #1, utilizing Novo Nordisk’s(R) semaglutide (Ozempic(R), Rybelsus(R)) was reported on in January 2024, and human pilot study #2, using the same drug, is expected to be reported on in August and September, 2024.</p> <p>Lexaria has made notable progress, having commenced another research program, the completion of which is set for August. This program will be executed by the National Research Council of Canada (“NRC”). It will seek to evaluate the molecular properties of DehydraTECH-processed pure semaglutide using simulated gastric fluid, which mimics conditions in the human gut.</p> <p>Lexaria also looks to follow through with its chronic (12-week) dosing human study set to be carried out in Australia. This study, which will involve 70-90 human study subjects with pre-diabetic and Type 2 diabetic conditions, will be run in Australia, and preparations have already begun. It will leverage the use of Rybelsus as a positive control, and then in four additional separate arms, DehydraTECH-processed 1) semaglutide, 2)CBD, 3) tirzepatide, and 4) combo CBD plus semaglutide This larger study will be registered as a Phase 1 level study and carried out into 2025.</p> <p>Human Pilot Study #3 is also in the pipeline, a study that will enroll up to eight healthy human volunteers, intending to evaluate DehydraTECH’s effectiveness in combination with a dual action GLP-1 agonist and glucose-dependent insulinotropic peptide (“GIP”) drug, Eli Lilly’s(R) well-known tirzepatide. The study will aim for several endpoints, including blood sugar, pharmacokinetics, and tolerability. Already, the company has brought a contract research organization (“CRO”) to run the study and is expecting to begin dosing in September.</p> <p>Lexaria is bullish about its GLP-1 studies, since revenues for this product class exceeded $31 billion, with the market projected to grow significantly in the coming years. The company continues to make progress toward this extremely high-value target.</p> <p>For more information, visit the company’s website at <a href="http://www.lexariabioscience.com/" target="_blank" rel="noreferrer noopener">www.LexariaBioscience.com</a>.</p> <p><strong>NOTE TO INVESTORS:</strong> The latest news and updates relating to LEXX are available in the company’s newsroom at <a href="https://ibn.fm/LEXX" target="_blank" rel="noreferrer noopener">https://ibn.fm/LEXX</a></p> <p><strong>About TinyGems</strong></p> <p><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">TinyGems</a> is a specialized communications platform with a focus on innovative small-cap and mid-cap companies with bright futures and huge potential. It is one of 60+ brands within the <a href="https://www.investorbrandnetwork.com/dynamic-brand-portfolio/" target="_blank" rel="noreferrer noopener"><strong>Dynamic Brand Portfolio</strong></a> @ <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener"><strong>IBN</strong></a> that delivers<strong>:</strong> (1) access to a vast network of wire solutions via <a href="https://www.investorwire.com/" target="_blank" rel="noreferrer noopener">InvestorWire</a> to efficiently and effectively reach a myriad of target markets, demographics and diverse industries<strong>;</strong> (2) article and <a href="https://www.investorbrandnetwork.com/solutions/press-distribution-via-investorwire/syndication-partners/" target="_blank" rel="noreferrer noopener">editorial syndication to 5,000+ outlets</a><strong>;</strong> (3) enhanced <a href="https://www.investorwire.com/investorwire-press-distribution/press-release-enhancement/" target="_blank" rel="noreferrer noopener">press release enhancement</a> to ensure maximum impact<strong>;</strong> (4) <a href="https://www.investorbrandnetwork.com/social-media-network/" target="_blank" rel="noreferrer noopener">social media distribution</a> via IBN to millions of social media followers<strong>;</strong> and (5) a full array of tailored <a href="https://www.investorbrandnetwork.com/solutions/" target="_blank" rel="noreferrer noopener">corporate communications solutions</a>. With broad reach and a seasoned team of contributing journalists and writers, TinyGems is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, TinyGems brings its clients unparalleled recognition and brand awareness. TinyGems is where breaking news, insightful content and actionable information converge.</p> <p><strong>To receive SMS alerts from TinyGems, text “Gems” to 888-902-4192 (U.S. Mobile Phones Only)</strong></p> <p>For more information, please visit <a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com</a></p> <p>Please see full terms of use and disclaimers on the TinyGems website applicable to all content provided by TinyGems, wherever published or re-published: <a href="https://tinygems.com/Disclaimer" target="_blank" rel="noreferrer noopener">https://www.TinyGems.com/Disclaimer</a></p> <p>TinyGems<br>Los Angeles, CA<br><a href="https://tinygems.com/" target="_blank" rel="noreferrer noopener">www.TinyGems.com</a><br>310.299.1717 Office<br><a href="mailto:Editor@TinyGems.com" target="_blank" rel="noreferrer noopener">Editor@TinyGems.com</a></p> <p>TinyGems is powered by <a href="https://www.investorbrandnetwork.com/" target="_blank" rel="noreferrer noopener">IBN</a></p> </div> <nav class="navigation post-navigation" aria-label="Posts"> <h2 class="screen-reader-text">Post navigation</h2> <div class="nav-links"><div class="nav-previous"><a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-exploring-alternative-diabetes-and-obesity-treatments/" rel="prev"><span class="meta-nav" aria-hidden="true">Previous</span> <span class="screen-reader-text">Previous post:</span> <span class="post-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments</span></a></div><div class="nav-next"><a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-targeting-oral-glp-1-alternatives-for-diabetes-and-obesity-treatment/" rel="next"><span class="meta-nav" aria-hidden="true">Next</span> <span class="screen-reader-text">Next post:</span> <span class="post-title">Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment</span></a></div></div> </nav> </div> <div class="single-article-right"> <div class="ad-sidebar"></div> <aside id="secondary" class="sidebar widget-area" role="complementary"> <section id="recent-posts-2" class="widget widget_recent_entries"> <h2 class="widget-title">Recent Articles</h2> <ul> <li> <a href="https://tinygems.com/calidi-biotherapeutics-inc-nyse-american-cldi-shares-data-supporting-innovative-proprietary-systemic-antitumor-platform/">Calidi Biotherapeutics Inc. (NYSE American: CLDI) Shares Data Supporting Innovative Proprietary Systemic Antitumor Platform</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-hires-new-ceo-amid-shift-in-focus-to-pharmaceutical-industry-collaboration-and-operations/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Hires New CEO Amid Shift in Focus to Pharmaceutical Industry Collaboration and Operations</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-demonstrates-continued-dehydratechtm-liraglutide-performance-with-ongoing-glp-1-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Demonstrates Continued DehydraTECH(TM)-Liraglutide Performance with Ongoing GLP-1 Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-yields-extremely-interesting-results-for-dehydratechtm-liraglutide-in-ongoing-diabetes-animal-study/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Yields “Extremely Interesting” Results for DehydraTECH(TM) Liraglutide in Ongoing Diabetes Animal Study</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-s-nasdaq-inm-inm-901-a-promising-new-candidate-for-alzheimers-therapy/">InMed Pharmaceuticals Inc.’s (NASDAQ: INM) INM-901: A Promising New Candidate for Alzheimer’s Therapy</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-validates-technologys-superiority-moving-closer-to-a-share-in-the-global-diabetes-treatment-market/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Validates Technology’s Superiority, Moving Closer to a Share in the Global Diabetes Treatment Market</a> </li> <li> <a href="https://tinygems.com/inmed-pharmaceuticals-inc-nasdaq-inm-reports-promising-long-term-results-for-alzheimers-drug-inm-901/">InMed Pharmaceuticals Inc. (NASDAQ: INM) Reports Promising Long-Term Results for Alzheimer’s Drug INM-901</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-targeting-oral-glp-1-alternatives-for-diabetes-and-obesity-treatment/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Targeting Oral GLP-1 Alternatives for Diabetes and Obesity Treatment</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-releases-q3-2024-financial-results-offers-a-roadmap-for-its-key-glp-1-study-program/" aria-current="page">Lexaria Bioscience Corp. (NASDAQ: LEXX) Releases Q3 2024 Financial Results; Offers a Roadmap for its Key GLP-1 Study Program</a> </li> <li> <a href="https://tinygems.com/lexaria-bioscience-corp-nasdaq-lexx-exploring-alternative-diabetes-and-obesity-treatments/">Lexaria Bioscience Corp. (NASDAQ: LEXX) Exploring Alternative Diabetes and Obesity Treatments</a> </li> </ul> </section> </aside> <h2>Archives</h2> <div class="selectamonth">Select A Month</div> <div class="sam-outer-container"> <div class="sam-inner-container"> <div class="sam-panel"> <li><a href='https://tinygems.com/2024/11/'>November 2024</a></li> <li><a href='https://tinygems.com/2024/09/'>September 2024</a></li> <li><a href='https://tinygems.com/2024/08/'>August 2024</a></li> <li><a href='https://tinygems.com/2024/07/'>July 2024</a></li> <li><a href='https://tinygems.com/2024/06/'>June 2024</a></li> <li><a href='https://tinygems.com/2024/05/'>May 2024</a></li> <li><a href='https://tinygems.com/2024/04/'>April 2024</a></li> <li><a href='https://tinygems.com/2024/03/'>March 2024</a></li> <li><a href='https://tinygems.com/2024/02/'>February 2024</a></li> <li><a href='https://tinygems.com/2024/01/'>January 2024</a></li> <li><a href='https://tinygems.com/2023/12/'>December 2023</a></li> <li><a href='https://tinygems.com/2023/11/'>November 2023</a></li> <li><a href='https://tinygems.com/2023/10/'>October 2023</a></li> <li><a href='https://tinygems.com/2023/09/'>September 2023</a></li> <li><a href='https://tinygems.com/2023/08/'>August 2023</a></li> <li><a href='https://tinygems.com/2023/07/'>July 2023</a></li> <li><a href='https://tinygems.com/2023/06/'>June 2023</a></li> <li><a href='https://tinygems.com/2023/05/'>May 2023</a></li> <li><a href='https://tinygems.com/2023/04/'>April 2023</a></li> <li><a href='https://tinygems.com/2023/03/'>March 2023</a></li> <li><a href='https://tinygems.com/2023/02/'>February 2023</a></li> <li><a href='https://tinygems.com/2023/01/'>January 2023</a></li> <li><a href='https://tinygems.com/2022/12/'>December 2022</a></li> <li><a href='https://tinygems.com/2022/11/'>November 2022</a></li> <li><a href='https://tinygems.com/2022/10/'>October 2022</a></li> <li><a href='https://tinygems.com/2022/09/'>September 2022</a></li> <li><a href='https://tinygems.com/2022/08/'>August 2022</a></li> <li><a href='https://tinygems.com/2022/07/'>July 2022</a></li> <li><a href='https://tinygems.com/2022/06/'>June 2022</a></li> <li><a href='https://tinygems.com/2022/05/'>May 2022</a></li> </div> </div> </div> </div> </article> </div> </div>   <div class="red-panel"> <div class="container"> <p>Contact us: <span>(310) 299-1717</span></p> </div> </div>  <div class="footer"> <div class="container"> <div class="quarter"> <a href="https://tinygems.com/"><img src="https://tinygems.com/wp-content/themes/tinygems/images/tinygems-white.png" alt="TinyGems" title="TinyGems"/></a> <h6><a href="https://tinygems.com/">TinyGems</a></h6> <p>8033 Sunset Blvd. Suite TG-1037 <br/>Los Angeles, CA 90046 <br/>(310) 299-1717</p> <ul class="social"> <li class="twitter"><a href="https://twitter.com/tinygems" target="_blank" rel="nofollow"></a></li> <li class="linkedin"><a href="https://www.linkedin.com/company/5133985?trk=tyah&trkInfo=tarId%3A1402372889813%2Ctas%3Atinygem%2Cidx%3A1-1-1" target="_blank" rel="nofollow"></a></li> <li class="facebook"><a href="https://www.facebook.com/tinygems.net" target="_blank" rel="nofollow"></a></li> </ul> </div> <div class="quarter"> <div class="menu-footer-solutions-container"><ul id="menu-footer-solutions" class="menu"><li id="menu-item-31334" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-31334"><a href="https://tinygems.com/tiny-gems/">Tiny Gems</a></li> <li id="menu-item-33891" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-33891"><a href="https://tinygems.com/newsroom/">NewsRoom</a></li> <li id="menu-item-34479" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34479"><a href="https://tinygems.com/newsletter-archives/">Newsletter Archives</a></li> <li id="menu-item-34873" class="menu-item menu-item-type-custom menu-item-object-custom menu-item-34873"><a target="_blank" rel="noopener" href="https://www.investorbrandnetwork.com/events/">Events</a></li> </ul></div> </div> <div class="quarter"> <div class="menu-footer-other-container"><ul id="menu-footer-other" class="menu"><li id="menu-item-34480" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34480"><a href="https://tinygems.com/about/">About</a></li> <li id="menu-item-34481" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-privacy-policy menu-item-34481"><a rel="privacy-policy" href="https://tinygems.com/disclaimer/">Disclaimer</a></li> <li id="menu-item-34482" class="menu-item menu-item-type-post_type menu-item-object-page menu-item-34482"><a href="https://tinygems.com/contact/">Contact</a></li> </ul></div> </div> <div class="quarter"> <div class="quickquote"> <h6>Quote / Research</h6> <input type="text" id="SymbolField" placeholder="Enter Symbol"> <a href="" class="getQuote">Get Quote</a> <h6 class="sitesearch">Site Search</h6> <form role="search" method="get" class="search-form" action="https://tinygems.com/"> <input type="search" class="search-field" placeholder="Search Term …" value="" name="s" /> <button type="submit" class="search-submit">Search</button> </form> </div> </div> <div class="copyright"> <p>Copyright © <script language="JavaScript" type="text/javascript"> var d=new Date(); yr=d.getFullYear(); if (yr!=2020) document.write("2020 - "+yr); else {document.write(""+yr);} </script>. TinyGems / 8033 Sunset Blvd. Suite TG-1037, Los Angeles, CA 90046 (310) 299-1717 / <a href="/disclaimer">Disclaimers</a></p> <p class="captcha-statement">Forms are protected by reCAPTCHA and the Google <a href="https://policies.google.com/privacy" target="_blank" rel="noopener noreferrer">Privacy Policy</a> and <a href="https://policies.google.com/terms" target="_blank" rel="noopener noreferrer">Terms of Service</a> apply.</p> </div> </div> </div>  <script id="tawk-script" type="text/javascript"> var Tawk_API = Tawk_API || {}; var Tawk_LoadStart=new Date(); (function(){ var s1 = document.createElement( 'script' ),s0=document.getElementsByTagName( 'script' )[0]; s1.async = true; s1.src = 'https://embed.tawk.to/6310b06854f06e12d8922d61/1gbsj268n'; s1.charset = 'UTF-8'; s1.setAttribute( 'crossorigin','*' ); s0.parentNode.insertBefore( s1, s0 ); })(); </script>  <script type="text/javascript" id="ges_angular_script-js-extra"> /* <![CDATA[ */ var wp_data = {"ajaxurl":"https:\/\/tinygems.com\/wp-admin\/admin-ajax.php","symbol":null}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/ang-script.js?1732381775" id="ges_angular_script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/swv/js/index.js" id="swv-js"></script> <script type="text/javascript" id="contact-form-7-js-extra"> /* <![CDATA[ */ var wpcf7 = {"api":{"root":"https:\/\/tinygems.com\/wp-json\/","namespace":"contact-form-7\/v1"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/includes/js/index.js" id="contact-form-7-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/skip-link-focus-fix.js" id="tinygems-skip-link-focus-fix-js"></script> <script type="text/javascript" id="tinygems-script-js-extra"> /* <![CDATA[ */ var screenReaderText = {"expand":"expand child menu","collapse":"collapse child menu"}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/functions.js" id="tinygems-script-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/js.cookie.min.js" id="tinygems-cookies-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/custom.js" id="tinygems-myscripts-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.min.js" id="tinygems-cycle-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-content/themes/tinygems/js/jquery.cycle2.scrollVert.min.js" id="tinygems-cycle-vert-js"></script> <script type="text/javascript" src="https://www.google.com/recaptcha/api.js?render=6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA" id="google-recaptcha-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill-inert.min.js" id="wp-polyfill-inert-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/regenerator-runtime.min.js" id="regenerator-runtime-js"></script> <script type="text/javascript" src="https://tinygems.com/wp-includes/js/dist/vendor/wp-polyfill.min.js" id="wp-polyfill-js"></script> <script type="text/javascript" id="wpcf7-recaptcha-js-extra"> /* <![CDATA[ */ var wpcf7_recaptcha = {"sitekey":"6LdoYukfAAAAANjIa2I8Gxc0Ty_xdMITmbwMhOmA","actions":{"homepage":"homepage","contactform":"contactform"}}; /* ]]> */ </script> <script type="text/javascript" src="https://tinygems.com/wp-content/plugins/contact-form-7/modules/recaptcha/index.js" id="wpcf7-recaptcha-js"></script> </body> </html>